Hematology / Oncology

With a vision for the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and the Emory University School of Medicine to be national leaders in pediatric hematology/oncology, and blood and marrow transplantation (BMT), we are excited to share that we had an extraordinary 2020. A few of our accomplishments include expanding our team, launching new programs and receiving multimillion dollar grants.

• Our team is more than five times the size it was 20 years ago, now with more than 115 faculty members.
• We continue our strong partnership with Aflac Inc., with more than$130 million in philanthropic contributions over the past 20-plus years.
• Our new Cancer Predisposition Program provides care for children who are at risk for developing cancer due to a cancer predisposition syndrome, family history of cancer or diagnosis of a rare type of cancer.
• We received a $4.5 million grant to launch the Cancer Precision Medicine Program, treating high risk or refractory cancer patients.
• We generated direct costs of more than $20.2 million last year in extramural research funding, including more than $50 million from the National Institutes of Health (NIH).
• We are the pediatric component of the Winship Cancer Institute of Emory University, the first and only comprehensive National Cancer Institute (NCI)-designated cancer institute in Georgia.

We are very grateful for the collaborative relationships we have with other pediatric hematologists and oncologists nationwide.

For more information, please visit here.
 
Douglas K. Graham, MD, PhD
Professor of Pediatrics
William G. Woods Chair
Chief, Aflac Cancer & Blood Disorders Center
Children’s Healthcare of Atlanta
Division Chief, Pediatric Hematology/Oncology/BMT
Emory University School of Medicine